Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas

Publisher： Karger

E-ISSN： 1423-0232|71|1-2|32-39

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.1-2, 2007-04, pp. : 32-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Tandem High-Dose Ifosfamide, Carboplatin, Etoposide Therapy with Stem Cell Rescue for Small-Cell Lung Cancer: Brief Report on the Results of a Phase-I/II Trial

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 248-253

Karger

Access to resources Recommend Favorite

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

ICE (Ifosfamide, Carboplatin, Etoposide) Chemotherapy and Systemic Hyperthermia

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 10-11

Karger

Access to resources Recommend Favorite

UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 33, Iss. 1, 2018-02 ,pp. : 46-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 110-117

Karger

Access to resources Recommend Favorite